Supernus Pharmaceuticals | SUPN - Stock


Supernus Pharmaceuticals reported $107.1M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
ANI Pharmaceuticals USD 143.07M 3.41M Dec/2025
Aurora Cannabis CAD 221.96M 6.3M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Canopy Growth CAD 102.37M 8.55M Sep/2025
Cara Therapeutics USD 900K 0 Mar/2025
Corcept Therapeutics USD 12.87M 519K Dec/2025
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Pacira USD 152.86M 4.82M Dec/2025
Perrigo USD 1.15B 78M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
United Therapeutics USD 183.1M 6.6M Dec/2025
Xeris Pharmaceuticals USD 68.67M 1.21M Dec/2025